ARQT logo

Arcutis Biotherapeutics (ARQT) Cash from investing

annual CFI:

$28.82M-$151.41M(-84.01%)
December 31, 2024

Summary

  • As of today (May 24, 2025), ARQT annual cash flow from investing activities is $28.82 million, with the most recent change of -$151.41 million (-84.01%) on December 31, 2024.
  • During the last 3 years, ARQT annual CFI has risen by +$104.77 million (+137.94%).
  • ARQT annual CFI is now -84.01% below its all-time high of $180.23 million, reached on December 31, 2023.

Performance

ARQT Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARQTcash flow metrics

quarterly CFI:

$11.75M-$23.13M(-66.31%)
March 31, 2025

Summary

  • As of today (May 24, 2025), ARQT quarterly cash flow from investing activities is $11.75 million, with the most recent change of -$23.13 million (-66.31%) on March 31, 2025.
  • Over the past year, ARQT quarterly CFI has increased by +$40.45 million (+140.95%).
  • ARQT quarterly CFI is now -89.10% below its all-time high of $107.75 million, reached on March 31, 2023.

Performance

ARQT quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARQTcash flow metrics

TTM CFI:

$69.27M+$40.45M(+140.34%)
March 31, 2025

Summary

  • As of today (May 24, 2025), ARQT TTM cash flow from investing activities is $69.27 million, with the most recent change of +$40.45 million (+140.34%) on March 31, 2025.
  • Over the past year, ARQT TTM CFI has increased by +$25.48 million (+58.20%).
  • ARQT TTM CFI is now -75.66% below its all-time high of $284.62 million, reached on September 30, 2023.

Performance

ARQT TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARQTcash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

ARQT Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-84.0%+140.9%+58.2%
3 y3 years+137.9%-23.2%+156.5%
5 y5 years+209.5%+157.8%+285.3%

ARQT Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-84.0%+133.1%-89.1%+106.0%-75.7%+156.5%
5 y5-year-84.0%+115.8%-89.1%+106.0%-75.7%+125.6%
alltimeall time-84.0%+115.8%-89.1%+106.0%-75.7%+125.6%

ARQT Cash from investing History

DateAnnualQuarterlyTTM
Mar 2025
-
$11.75M(-66.3%)
$69.27M(+140.3%)
Dec 2024
$28.82M(-84.0%)
$34.88M(-58.9%)
$28.82M(-142.2%)
Sep 2024
-
$84.78M(-236.4%)
-$68.24M(-36.5%)
Jun 2024
-
-$62.14M(+116.5%)
-$107.47M(-345.5%)
Mar 2024
-
-$28.70M(-53.9%)
$43.78M(-75.7%)
Dec 2023
$180.23M(-306.7%)
-$62.19M(-236.5%)
$180.23M(-36.7%)
Sep 2023
-
$45.55M(-48.9%)
$284.62M(+580.8%)
Jun 2023
-
$89.12M(-17.3%)
$41.81M(+695.6%)
Mar 2023
-
$107.75M(+155.3%)
$5.25M(-106.0%)
Dec 2022
-$87.20M(+14.8%)
$42.20M(-121.4%)
-$87.20M(-17.7%)
Sep 2022
-
-$197.26M(-475.3%)
-$105.90M(-211.7%)
Jun 2022
-
$52.56M(+243.6%)
$94.83M(-177.3%)
Mar 2022
-
$15.30M(-34.9%)
-$122.65M(+61.5%)
DateAnnualQuarterlyTTM
Dec 2021
-$75.95M(-58.2%)
$23.50M(+577.0%)
-$75.95M(-56.7%)
Sep 2021
-
$3.47M(-102.1%)
-$175.34M(-35.2%)
Jun 2021
-
-$164.92M(-366.0%)
-$270.53M(+171.9%)
Mar 2021
-
$62.00M(-181.7%)
-$99.50M(-45.3%)
Dec 2020
-$181.82M(+590.7%)
-$75.89M(-17.2%)
-$181.82M(+28.1%)
Sep 2020
-
-$91.71M(-1602.2%)
-$141.93M(+387.3%)
Jun 2020
-
$6.11M(-130.0%)
-$29.12M(-22.1%)
Mar 2020
-
-$20.33M(-43.5%)
-$37.38M(+42.0%)
Dec 2019
-$26.32M(+128.3%)
-$36.00M(-270.6%)
-$26.32M(-372.1%)
Sep 2019
-
$21.10M(-1080.3%)
$9.67M(-184.7%)
Jun 2019
-
-$2.15M(-76.8%)
-$11.42M(+23.2%)
Mar 2019
-
-$9.27M
-$9.27M
Dec 2018
-$11.53M(<-9900.0%)
-
-
Dec 2017
$0.00
-
-

FAQ

  • What is Arcutis Biotherapeutics annual cash flow from investing activities?
  • What is the all time high annual CFI for Arcutis Biotherapeutics?
  • What is Arcutis Biotherapeutics annual CFI year-on-year change?
  • What is Arcutis Biotherapeutics quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Arcutis Biotherapeutics?
  • What is Arcutis Biotherapeutics quarterly CFI year-on-year change?
  • What is Arcutis Biotherapeutics TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Arcutis Biotherapeutics?
  • What is Arcutis Biotherapeutics TTM CFI year-on-year change?

What is Arcutis Biotherapeutics annual cash flow from investing activities?

The current annual CFI of ARQT is $28.82M

What is the all time high annual CFI for Arcutis Biotherapeutics?

Arcutis Biotherapeutics all-time high annual cash flow from investing activities is $180.23M

What is Arcutis Biotherapeutics annual CFI year-on-year change?

Over the past year, ARQT annual cash flow from investing activities has changed by -$151.41M (-84.01%)

What is Arcutis Biotherapeutics quarterly cash flow from investing activities?

The current quarterly CFI of ARQT is $11.75M

What is the all time high quarterly CFI for Arcutis Biotherapeutics?

Arcutis Biotherapeutics all-time high quarterly cash flow from investing activities is $107.75M

What is Arcutis Biotherapeutics quarterly CFI year-on-year change?

Over the past year, ARQT quarterly cash flow from investing activities has changed by +$40.45M (+140.95%)

What is Arcutis Biotherapeutics TTM cash flow from investing activities?

The current TTM CFI of ARQT is $69.27M

What is the all time high TTM CFI for Arcutis Biotherapeutics?

Arcutis Biotherapeutics all-time high TTM cash flow from investing activities is $284.62M

What is Arcutis Biotherapeutics TTM CFI year-on-year change?

Over the past year, ARQT TTM cash flow from investing activities has changed by +$25.48M (+58.20%)
On this page